Clinical Trials in Spain — Country Dashboard | 4,847 EU Studies

Filter these 4,847 trials by condition, phase, sponsor and more.

Open in Search →

4,847 Registered trials

1,866 Recruiting

2,540 Completed trials

1,158 Sponsors active

827 Research sites

Phase III

Phase II

Phase III: 1858 Phase II/III: 195 Phase II: 1245 Phase I/II: 318 Phase III/IV: 55 Phase IV: 271 Phase I: 331 Phase I (Other): 273 Phase I (FiH): 244 Other: 54 Other: 3

Oversight events in trials active here:

133 serious breaches 1018 temporary halts 82 urgent safety measures 101 unexpected events 158 corrective measures across 562 trials

View oversight register →

Top conditions

Non-small cell lung cancer 189 Non-small cell lung cancer metastatic 61 Ovarian cancer 55 Colorectal cancer 48 Breast cancer 48 Systemic lupus erythematosus 41 Endometrial cancer 35 Squamous cell carcinoma of head and neck 35 Myelodysplastic syndrome 32 Diffuse large B-cell lymphoma 30 Triple negative breast cancer 30 Prostate cancer metastatic 29

Top sponsors

AstraZeneca AB 203 Merck Sharp & Dohme LLC 200 Novartis Pharma AG 182 F. Hoffmann-La Roche AG 165 Janssen - Cilag International 145 AbbVie Deutschland GmbH & Co. KG 113 Pfizer Inc. 98 Glaxosmithkline Research & Development Limited 78 Bristol-Myers Squibb Services Unlimited Company 77 Sanofi-Aventis Recherche & Developpement 74 Boehringer Ingelheim International GmbH 72 Amgen Inc. 71

Cities with most trials

All 231 cities →

All trials — page 21

4,847 total

Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting

2025-522896-27-00 Phase II Asthma Sanofi-Aventis Recherche & Developpement
INTRATUMORAL DNX-2401 ADMINISTRATION FOR RECURRENT AND REFRACTORY HIGH GRADE BRAIN TUMORS IN PEDIATRIC AND YOUNG ADULT PATIENTS Recruiting

2024-515009-24-00 Phase II High grade malignant brain neoplasm Clinica Universidad De Navarra
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Phase II/III Pretreated Unresectable Locally Advanced or Metastatic human… F. Hoffmann-La Roche AG
Phase 2 Study of REGN13335 in Adult Participants with Pulmonary Arterial Hypertension (PAH) Recruiting

2024-514754-79-00 Phase II Pulmonary Arterial Hypertension (PAH) Regeneron Pharmaceuticals Inc.
Efficacy and safety study of intravenous brincidofovir compared to intravenous cidofovir for the treatment of adenovirus infection in childr… Recruiting

2025-521903-28-00 Phase III Adenovirus viremia Symbio Pharmaceuticals Ltd.
Phase 3 study comparing ivonescimab alone or ivonescimab with ligufalimab versus pembrolizumab for the first-line treatment of recurrent and… Recruiting

2025-522996-27-00 Phase III recurrent and/or metastatic squamous cell carcinoma of the h… Groupe Oncologie Radiotherapie Tete Cou
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Phase III Ovarian cancer Merck Sharp & Dohme LLC
A Study of YL201 in Combination with Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors Recruiting

2025-523742-27-00 Phase I/II Advanced solid tumors Medilink Therapeutics (Suzhou) Co. Ltd.
Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Phase III Polyarticular-course juvenile idiopathic arthritis Alfasigma S.p.A.
A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting

2024-519830-22-00 Phase III Heart failure due to systemic left ventricular systolic dysf… Bayer AG
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/… Recruiting

2025-522484-15-00 Phase III ER+/HER2- early breast cancer WSG Westdeutsche Studiengruppe GmbH
L19IL2/TNF in patients with basal cell carcinoma Recruiting

2025-523230-77-00 Phase II Patients with locally advanced Basal Cell Carcinoma (LaBCC) … Philogen S.p.A.
L19IL2/L19TNF in patients with cutaneous squamous cell carcinoma Recruiting

2025-523231-19-00 Phase II Cutaneous Squamous Cell Carcinoma Philogen S.p.A.
A multi-centre, single-arm study to demonstrate the efficacy of bone marrow allogeneic mesenchymal cells combined with biomaterial (combined… Recruiting

2025-520841-60-00 Phase III Delayed consolidation or non-union long bone fracture Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De H…
Evaluating a Personalized Treatment Strategy for Young Women with Early Breast Cancer Recruiting

2024-519655-28-00 Phase III Premenopausal patients with high-risk HR-positive/HER2-negat… Unicancer
A study to assess the effects of zigakibart on IgA nephropathy. Recruiting

2024-519699-24-00 Phase II IgA nephropathy Novartis Pharma AG
Study to Evaluate the Efficacy and Safety of Deucrictibant for Prophylactic and On-demand Treatment of Angioedema Attacks in Adults with Acq… Recruiting

2025-522051-26-00 Phase III Acquired Angioedema due to C1 Inhibitor Deficiency Pharvaris Netherlands B.V.
Phase 1 trial of valemetostat and darolutamide in mCRPC Recruiting

2025-522512-16-00 Phase I (Other) Metastatic Castration Resistant Prostate Cancer (mCRPC) Daiichi Sankyo Inc.
A study for adolescents who are depressed and thinking of suicide Recruiting

2024-518615-19-00 Phase III Major Depressive Disorder Janssen Cilag International
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Phase III Pulmonary Hypertension associated with interstitial lung dis… Liquidia Technologies Inc.
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting

2025-522878-36-00 Phase III Chronic Spontaneous Urticaria Celldex Therapeutics Inc.
A Study of Transition Regimens to KPL-387 Monotherapy in Participants with Well-Controlled Recurrent Pericarditis Recruiting

2025-523234-66-00 Phase II Well-Controlled Recurrent Pericarditis Kiniksa Pharmaceuticals GmbH
A study to test the safety and disease progression following YTB323 (rapcabtagene autoleucel) administration in participant with progressive… Recruiting

2024-514006-31-00 Phase I/II Non-active Progressive Multiple Sclerosis (PMS) Novartis Pharma AG
A clinical study of MK-1084 with other treatments for non-small cell lung cancer (MK-3475-01F) Recruiting

2024-512248-47-00 Phase I/II Non-small Cell Lung Cancer (NSCLC) Merck Sharp & Dohme LLC

Showing 481–504 of 4,847 trials

← All countries